Now that global regulators have approved four oral solid-dosage drugs that were made using continuous processes two from Vertex (in 2015 and 2018), one from Janssen (in 2016), and one from Eli Lilly (in 2017) equipment manufacturers and early adopters are working to resolve engineering challengeOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.